Free Trial

Sapiens International (SPNS) Financials

Sapiens International logo
$26.24 +0.11 (+0.42%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$26.06 -0.18 (-0.69%)
As of 07:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Sapiens International

Annual Income Statements for Sapiens International

This table shows Sapiens International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
14 20 19 0.35 14 26 34 47 53 62 72
Consolidated Net Income / (Loss)
15 20 20 0.56 14 26 34 47 53 63 72
Net Income / (Loss) Continuing Operations
15 20 20 0.56 14 26 34 47 53 63 72
Total Pre-Tax Income
15 25 25 -2.01 19 35 41 57 66 77 90
Total Operating Income
15 24 25 1.00 23 38 45 57 66 79 86
Total Gross Profit
58 74 86 94 110 130 156 188 200 220 238
Total Revenue
157 186 216 269 290 326 383 461 475 515 542
Operating Revenue
157 186 216 269 290 326 383 461 475 515 542
Total Cost of Revenue
99 111 130 176 180 196 227 273 275 295 304
Operating Cost of Revenue
99 111 130 176 180 196 227 273 275 295 304
Total Operating Expenses
43 50 61 93 87 92 111 130 134 141 152
Selling, General & Admin Expense
32 40 44 61 52 54 70 76 75 77 86
Research & Development Expense
11 10 16 32 34 37 41 54 59 63 66
Total Other Income / (Expense), net
0.12 0.16 0.53 -3.01 -3.99 -2.77 -3.81 -0.20 -0.94 -1.75 3.98
Other Income / (Expense), net
0.12 - 0.53 -3.01 -3.99 -2.77 -3.81 -0.20 -0.94 -1.75 3.98
Income Tax Expense
0.45 4.21 5.77 -2.56 5.03 8.61 7.04 9.96 13 14 18
Net Income / (Loss) Attributable to Noncontrolling Interest
0.11 0.28 0.27 0.20 0.22 0.24 0.38 0.15 0.34 0.42 0.14
Basic Earnings per Share
$0.31 $0.42 $0.40 $0.01 $0.28 $0.53 $0.67 $0.86 $0.95 $1.13 $1.29
Weighted Average Basic Shares Outstanding
47.68M 48.76M 49.04M 49.76M 0.00 50.16M 54.66M 55.07M 55.14M 55.73M 55.89M
Diluted Earnings per Share
$0.30 $0.41 $0.40 $0.01 $0.28 $0.52 $0.65 $0.85 $0.95 $1.12 $1.29
Weighted Average Diluted Shares Outstanding
47.68M 48.76M 49.04M 49.76M 0.00 50.16M 54.66M 55.07M 55.14M 55.73M 55.89M
Weighted Average Basic & Diluted Shares Outstanding
47.68M 48.76M 49.04M 49.76M 0.00 50.16M 54.66M 55.07M 55.14M 55.73M 55.89M

Quarterly Income Statements for Sapiens International

No quarterly income statements for Sapiens International are available.


Annual Cash Flow Statements for Sapiens International

This table details how cash moves in and out of Sapiens International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-23 6.95 5.16 11 -6.84 27 86 38 -30 -34 37
Net Cash From Operating Activities
22 40 26 9.25 28 66 58 81 44 79 82
Net Cash From Continuing Operating Activities
22 40 26 12 28 66 58 81 44 79 82
Net Income / (Loss) Continuing Operations
15 20 20 0.56 14 26 34 47 53 63 72
Consolidated Net Income / (Loss)
15 20 20 0.56 14 26 34 47 53 63 72
Depreciation Expense
8.72 9.63 10 16 20 19 23 29 4.24 3.87 4.37
Amortization Expense
-0.23 -0.45 -0.52 0.51 - - - 0.11 0.09 18 0.04
Non-Cash Adjustments To Reconcile Net Income
1.07 1.19 1.72 2.04 2.29 1.54 4.52 6.09 14 3.82 15
Changes in Operating Assets and Liabilities, net
-2.58 9.78 -4.79 -6.59 -8.30 19 -3.80 -1.65 -28 -8.76 -9.50
Net Cash From Investing Activities
-43 -19 -9.71 -73 -26 -42 -128 0.13 -12 -73 13
Net Cash From Continuing Investing Activities
-43 -19 -9.71 -73 -26 -19 -128 0.13 -13 -73 13
Purchase of Property, Plant & Equipment
-7.56 -8.85 -10 -2.62 -1.91 -11 -2.63 -3.79 -3.03 -2.57 -3.00
Acquisitions
-2.06 -2.93 -4.38 -106 -5.16 -5.67 -5.80 -7.08 -9.56 -15 -7.51
Sale of Property, Plant & Equipment
- - - 0.00 0.00 0.83 0.01 1.11 0.05 0.05 0.20
Sale and/or Maturity of Investments
1.54 1.50 14 35 - - - - -55 - -139
Other Investing Activities, net
0.24 -0.89 - 0.00 0.00 -1.12 20 9.88 55 60 162
Net Cash From Financing Activities
1.46 -14 -11 70 -9.43 -21 157 -40 -58 -43 -56
Net Cash From Continuing Financing Activities
1.46 -14 -11 70 -9.43 -21 157 -40 -58 -43 -56
Repayment of Debt
0.00 0.00 -0.82 -0.06 -0.24 -9.90 -30 -20 -20 -20 -20
Payment of Dividends
-0.11 -7.26 -9.86 -9.85 -10 -11 -7.04 -21 -39 -28 -36
Other Financing Activities, net
1.57 -6.91 -0.55 1.69 0.83 0.41 4.37 1.11 0.00 4.81 -0.53
Other Net Changes in Cash
- - - - - - - - -6.39 - -2.75
Cash Interest Paid
0.01 0.01 0.05 0.71 2.07 2.48 5.44 3.50 1.47 0.75 1.04
Cash Income Taxes Paid
0.67 2.23 1.20 2.71 2.85 6.40 16 9.05 13 30 26

Quarterly Cash Flow Statements for Sapiens International

No quarterly cash flow statements for Sapiens International are available.


Annual Balance Sheets for Sapiens International

This table presents Sapiens International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
233 242 258 374 379 452 714 715 668 690 692
Total Current Assets
83 98 120 131 130 147 267 300 285 315 335
Cash & Equivalents
47 54 61 71 65 66 153 190 160 127 164
Short-Term Investments
0.00 8.78 18 - 0.00 23 30 20 20 75 53
Accounts Receivable
32 30 35 53 59 50 65 76 93 90 100
Prepaid Expenses
3.96 5.46 6.39 6.28 6.22 7.82 19 14 12 23 19
Plant, Property, & Equipment, net
5.01 5.68 9.81 11 8.52 17 17 14 12 13 11
Total Noncurrent Assets
145 138 128 232 240 289 430 400 371 362 346
Goodwill
68 70 74 159 166 171 264 261 252 256 252
Intangible Assets
28 28 28 65 65 58 99 82 67 61 51
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - 3.12 9.42 11 13
Other Noncurrent Operating Assets
16 9.80 8.66 8.22 8.99 60 66 54 42 34 30
Total Liabilities & Shareholders' Equity
233 242 258 374 379 452 714 715 668 690 692
Total Liabilities
55 60 63 171 176 227 330 306 265 240 212
Total Current Liabilities
40 47 48 70 81 105 145 152 146 149 150
Short-Term Debt
- - - 0.00 9.90 9.90 20 20 20 20 20
Accounts Payable
3.31 4.72 6.56 7.04 6.15 5.11 5.39 5.01 9.42 6.29 8.41
Accrued Expenses
12 15 14 24 25 34 35 33 35 29 28
Current Deferred Revenue
9.27 10 9.14 17 18 21 35 40 31 39 38
Current Employee Benefit Liabilities
15 17 18 23 22 27 40 43 42 49 49
Other Current Liabilities
- - - - 0.00 8.31 9.92 11 9.06 6.62 6.44
Total Noncurrent Liabilities
15 13 15 101 95 122 185 154 119 91 62
Long-Term Debt
- - 0.00 78 69 59 99 79 59 40 20
Noncurrent Deferred & Payable Income Tax Liabilities
- - 2.17 9.17 12 5.08 16 15 11 11 6.90
Other Noncurrent Operating Liabilities
15 13 13 14 15 58 70 60 49 40 36
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
178 182 194 201 202 225 384 409 403 450 480
Total Preferred & Common Equity
178 181 194 200 201 224 382 407 401 447 480
Total Common Equity
178 181 194 200 201 224 382 407 401 447 480
Common Stock
250 235 227 222 216 218 335 342 345 354 356
Retained Earnings
-53 -33 -13 -13 2.67 18 45 72 86 120 160
Accumulated Other Comprehensive Income / (Loss)
-10 -12 -11 0.53 -7.82 -2.38 11 2.82 -21 -17 -27
Other Equity Adjustments
- - - - - - - - -9.42 -9.42 -9.42
Noncontrolling Interest
0.69 0.87 0.80 0.83 1.44 1.68 2.00 2.17 2.35 2.68 0.00

Quarterly Balance Sheets for Sapiens International

No quarterly balance sheets for Sapiens International are available.


Annual Metrics and Ratios for Sapiens International

This table displays calculated financial ratios and metrics derived from Sapiens International's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
16.30% 17.90% 16.46% 24.52% 7.62% 12.42% 17.57% 20.41% 2.97% 8.39% 5.40%
EBITDA Growth
15.93% 42.51% 4.05% -58.79% 170.62% 39.46% 19.07% 33.26% -18.81% 41.14% -4.44%
EBIT Growth
21.18% 62.01% 4.20% -107.91% 1,047.76% 84.44% 17.37% 39.05% 14.43% 17.65% 16.48%
NOPAT Growth
30.16% 39.49% -4.84% -96.34% 2,314.59% 68.75% 30.55% 27.28% 13.06% 19.75% 7.50%
Net Income Growth
25.74% 39.27% -3.44% -97.16% 2,417.99% 89.22% 28.94% 38.54% 11.85% 18.77% 15.04%
EPS Growth
11.11% 36.67% -2.44% -97.50% 2,700.00% 85.71% 25.00% 30.77% 11.76% 17.89% 15.18%
Operating Cash Flow Growth
24.88% 87.56% -35.61% -64.48% 199.52% 138.83% -11.94% 38.26% -45.64% 81.42% 3.53%
Free Cash Flow Firm Growth
4,049.17% 80.32% -71.80% -1,396.44% 108.82% 313.13% -295.10% 190.36% -29.79% 19.32% 24.48%
Invested Capital Growth
-2.14% -9.97% 12.19% 111.27% 3.49% -5.21% 56.11% -7.11% 1.47% 1.80% -1.35%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
37.06% 40.10% 39.68% 34.74% 37.82% 39.77% 40.73% 40.74% 42.16% 42.67% 43.90%
EBITDA Margin
14.94% 18.06% 16.13% 5.34% 13.42% 16.65% 16.87% 18.67% 14.72% 19.17% 17.38%
Operating Margin
9.47% 13.12% 11.49% 0.37% 7.95% 11.63% 11.75% 12.47% 14.01% 15.33% 15.83%
EBIT Margin
9.55% 13.12% 11.74% -0.75% 6.57% 10.78% 10.76% 12.43% 13.81% 14.99% 16.56%
Profit (Net Income) Margin
9.26% 10.94% 9.07% 0.21% 4.83% 8.13% 8.92% 10.26% 11.15% 12.22% 13.33%
Tax Burden Percent
96.98% 82.81% 77.25% -27.69% 73.56% 75.47% 82.91% 82.61% 80.75% 81.52% 80.51%
Interest Burden Percent
100.00% 100.67% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
3.02% 17.19% 22.75% 0.00% 26.44% 24.53% 17.09% 17.39% 19.25% 18.48% 19.49%
Return on Invested Capital (ROIC)
14.60% 21.67% 20.51% 0.46% 7.96% 13.56% 14.21% 15.38% 17.92% 21.12% 22.65%
ROIC Less NNEP Spread (ROIC-NNEP)
14.44% 21.51% 20.08% 0.78% -20.46% 76.96% 21.67% 15.57% 18.64% 22.29% 20.65%
Return on Net Nonoperating Assets (RNNOA)
-6.24% -10.41% -10.12% -0.18% -1.04% -1.19% -3.00% -3.45% -4.88% -6.38% -7.09%
Return on Equity (ROE)
8.36% 11.26% 10.38% 0.28% 6.92% 12.38% 11.20% 11.93% 13.04% 14.74% 15.56%
Cash Return on Invested Capital (CROIC)
16.76% 32.15% 9.02% -71.04% 4.54% 18.91% -29.61% 22.75% 16.47% 19.33% 24.01%
Operating Return on Assets (OROA)
6.60% 10.24% 10.15% -0.64% 5.06% 8.45% 7.06% 8.02% 9.48% 11.36% 13.01%
Return on Assets (ROA)
6.40% 8.54% 7.84% 0.18% 3.72% 6.37% 5.86% 6.62% 7.65% 9.26% 10.47%
Return on Common Equity (ROCE)
8.32% 11.19% 10.30% 0.28% 6.86% 12.29% 11.13% 11.86% 12.97% 14.65% 15.52%
Return on Equity Simple (ROE_SIMPLE)
8.21% 11.22% 10.12% 0.28% 6.96% 11.84% 8.95% 11.64% 13.22% 14.06% 15.08%
Net Operating Profit after Tax (NOPAT)
14 20 19 0.70 17 29 37 47 54 64 69
NOPAT Margin
9.18% 10.86% 8.88% 0.26% 5.85% 8.78% 9.74% 10.30% 11.31% 12.49% 12.74%
Net Nonoperating Expense Percent (NNEP)
0.16% 0.15% 0.43% -0.32% 28.42% -63.40% -7.46% -0.19% -0.71% -1.17% 2.01%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 11.14% 12.62% 13.31%
Cost of Revenue to Revenue
62.94% 59.90% 60.32% 65.26% 62.18% 60.23% 59.27% 59.26% 57.84% 57.33% 56.10%
SG&A Expenses to Revenue
20.39% 21.47% 20.57% 22.50% 18.00% 16.67% 18.18% 16.56% 15.80% 15.01% 15.85%
R&D to Revenue
7.21% 5.51% 7.63% 11.87% 11.88% 11.48% 10.80% 11.72% 12.36% 12.34% 12.22%
Operating Expenses to Revenue
27.60% 26.99% 28.19% 34.37% 29.87% 28.14% 28.98% 28.27% 28.16% 27.35% 28.07%
Earnings before Interest and Taxes (EBIT)
15 24 25 -2.01 19 35 41 57 66 77 90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
24 34 35 14 39 54 65 86 70 99 94
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.65 2.36 3.23 2.57 2.52 4.78 3.78 4.41 2.45 3.51 3.09
Price to Tangible Book Value (P/TBV)
3.57 5.12 6.81 0.00 0.00 0.00 79.80 28.31 12.13 12.08 8.36
Price to Revenue (P/Rev)
1.86 2.30 2.89 1.91 1.75 3.29 3.77 3.88 2.07 3.05 2.73
Price to Earnings (P/E)
20.26 21.33 32.30 1,457.81 36.78 40.77 42.75 37.97 18.64 25.13 20.53
Dividend Yield
0.00% 1.68% 1.56% 1.91% 3.93% 1.95% 1.25% 1.56% 3.93% 1.79% 2.12%
Earnings Yield
4.94% 4.69% 3.10% 0.07% 2.72% 2.45% 2.34% 2.63% 5.36% 3.98% 4.87%
Enterprise Value to Invested Capital (EV/IC)
2.18 3.79 5.36 2.50 2.41 5.13 4.32 5.66 2.92 4.65 4.31
Enterprise Value to Revenue (EV/Rev)
1.36 1.80 2.45 1.94 1.80 3.23 3.61 3.65 1.86 2.78 2.41
Enterprise Value to EBITDA (EV/EBITDA)
9.07 9.97 15.19 36.33 13.43 19.38 21.40 19.54 12.62 14.49 13.85
Enterprise Value to EBIT (EV/EBIT)
14.19 13.73 20.88 0.00 27.44 29.95 33.55 29.36 13.45 18.53 14.53
Enterprise Value to NOPAT (EV/NOPAT)
14.76 16.57 27.61 744.43 30.84 36.78 37.04 35.41 16.42 22.23 18.88
Enterprise Value to Operating Cash Flow (EV/OCF)
9.89 8.26 20.35 56.46 18.86 15.89 23.73 20.88 20.14 17.99 15.87
Enterprise Value to Free Cash Flow (EV/FCFF)
12.85 11.17 62.80 0.00 54.15 26.38 0.00 23.94 17.88 24.28 17.81
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.39 0.39 0.30 0.31 0.24 0.20 0.13 0.08
Long-Term Debt to Equity
0.00 0.00 0.00 0.39 0.34 0.26 0.26 0.19 0.15 0.09 0.04
Financial Leverage
-0.43 -0.48 -0.50 -0.23 0.05 -0.02 -0.14 -0.22 -0.26 -0.29 -0.34
Leverage Ratio
1.31 1.32 1.32 1.59 1.86 1.94 1.91 1.80 1.70 1.59 1.49
Compound Leverage Factor
1.31 1.33 1.32 1.59 1.86 1.94 1.91 1.80 1.70 1.59 1.49
Debt to Total Capital
0.00% 0.00% 0.00% 27.91% 27.93% 23.36% 23.57% 19.46% 16.40% 11.65% 7.62%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 3.52% 3.36% 3.94% 3.90% 4.11% 3.89% 3.81%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 27.91% 24.41% 20.00% 19.63% 15.56% 12.30% 7.76% 3.81%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.48% 0.69% 0.87% 0.78% 0.51% 0.57% 0.50% 0.45% 0.51% 0.53% 0.00%
Common Equity to Total Capital
99.52% 99.31% 99.13% 71.31% 71.56% 76.07% 75.93% 80.09% 83.09% 87.82% 92.38%
Debt to EBITDA
0.00 0.00 0.00 5.45 2.02 1.27 1.83 1.15 1.13 0.60 0.42
Net Debt to EBITDA
0.00 0.00 0.00 0.47 0.36 -0.38 -0.99 -1.30 -1.45 -1.45 -1.87
Long-Term Debt to EBITDA
0.00 0.00 0.00 5.45 1.76 1.09 1.53 0.92 0.85 0.40 0.21
Debt to NOPAT
0.00 0.00 0.00 111.61 4.63 2.41 3.18 2.08 1.47 0.92 0.57
Net Debt to NOPAT
0.00 0.00 0.00 9.71 0.82 -0.72 -1.72 -2.35 -1.89 -2.22 -2.56
Long-Term Debt to NOPAT
0.00 0.00 0.00 111.61 4.05 2.06 2.64 1.66 1.10 0.62 0.29
Altman Z-Score
4.01 5.43 7.42 2.65 2.82 3.97 3.65 4.81 3.68 5.58 6.05
Noncontrolling Interest Sharing Ratio
0.43% 0.58% 0.78% 0.98% 0.90% 0.73% 0.69% 0.60% 0.58% 0.60% 0.29%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.10 2.09 2.52 1.87 1.60 1.40 1.85 1.98 1.95 2.11 2.24
Quick Ratio
2.00 1.98 2.38 1.78 1.53 1.33 1.71 1.89 1.88 1.96 2.11
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
17 30 8.44 -109 9.65 40 -78 70 49 59 73
Operating Cash Flow to CapEx
285.12% 457.10% 255.06% 352.71% 1,447.23% 621.78% 2,222.63% 3,010.92% 1,473.58% 3,144.30% 2,937.66%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.69 0.78 0.86 0.85 0.77 0.78 0.66 0.65 0.69 0.76 0.79
Accounts Receivable Turnover
5.67 6.03 6.71 6.12 5.16 5.95 6.62 6.51 5.60 5.60 5.71
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
30.65 34.74 27.93 26.26 30.16 25.93 22.81 29.34 35.86 41.70 46.52
Accounts Payable Turnover
20.17 27.69 23.11 25.82 27.31 34.85 43.24 52.55 38.07 37.56 41.38
Days Sales Outstanding (DSO)
64.33 60.55 54.40 59.60 70.80 61.29 55.11 56.08 65.21 65.13 63.89
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
18.10 13.18 15.79 14.13 13.37 10.47 8.44 6.95 9.59 9.72 8.82
Cash Conversion Cycle (CCC)
46.23 47.37 38.61 45.46 57.43 50.82 46.67 49.13 55.63 55.42 55.07
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
98 88 99 209 216 205 320 297 302 307 303
Invested Capital Turnover
1.59 1.99 2.31 1.75 1.36 1.55 1.46 1.49 1.58 1.69 1.78
Increase / (Decrease) in Invested Capital
-2.14 -9.76 11 110 7.29 -11 115 -23 4.37 5.44 -4.14
Enterprise Value (EV)
213 334 530 522 522 1,051 1,382 1,682 882 1,429 1,305
Market Capitalization
293 427 625 513 507 1,070 1,444 1,791 980 1,569 1,482
Book Value per Share
$3.86 $3.80 $3.97 $4.08 $4.04 $4.46 $7.61 $7.44 $7.27 $8.11 $8.58
Tangible Book Value per Share
$1.78 $1.75 $1.88 ($0.48) ($0.61) ($0.10) $0.36 $1.16 $1.47 $2.36 $3.17
Total Capital
178 182 195 281 281 294 503 508 482 509 519
Total Debt
0.00 0.00 0.00 78 78 69 118 99 79 59 40
Total Long-Term Debt
0.00 0.00 0.00 78 69 59 99 79 59 40 20
Net Debt
-80 -94 -96 6.81 14 -20 -64 -111 -101 -143 -177
Capital Expenditures (CapEx)
7.56 8.85 10 2.62 1.91 11 2.62 2.68 2.97 2.53 2.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.74 -12 -6.68 -11 -5.82 -37 -40 -42 -21 -17 -11
Debt-free Net Working Capital (DFNWC)
44 51 72 61 59 52 142 168 159 186 205
Net Working Capital (NWC)
44 51 72 61 49 42 123 149 139 166 186
Net Nonoperating Expense (NNE)
-0.12 -0.13 -0.41 0.15 2.94 2.09 3.15 0.17 0.76 1.43 -3.20
Net Nonoperating Obligations (NNO)
-80 -94 -96 6.81 14 -20 -64 -111 -101 -143 -177
Total Depreciation and Amortization (D&A)
8.49 9.17 9.51 16 20 19 23 29 4.33 22 4.42
Debt-free, Cash-free Net Working Capital to Revenue
-2.37% -6.35% -3.09% -3.96% -2.01% -11.35% -10.49% -9.07% -4.45% -3.21% -2.00%
Debt-free Net Working Capital to Revenue
27.73% 27.66% 33.51% 22.59% 20.30% 16.03% 37.18% 36.54% 33.52% 36.06% 37.86%
Net Working Capital to Revenue
27.73% 27.66% 33.51% 22.59% 16.88% 12.99% 32.01% 32.24% 29.35% 32.22% 34.21%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.31 $0.42 $0.40 $0.01 $0.28 $0.53 $0.67 $0.86 $0.95 $1.13 $1.29
Adjusted Weighted Average Basic Shares Outstanding
47.68M 48.76M 49.04M 49.76M 0.00 50.16M 54.66M 55.07M 55.14M 55.73M 55.89M
Adjusted Diluted Earnings per Share
$0.30 $0.41 $0.40 $0.01 $0.28 $0.52 $0.65 $0.85 $0.95 $1.12 $1.29
Adjusted Weighted Average Diluted Shares Outstanding
47.68M 48.76M 49.04M 49.76M 0.00 50.16M 54.66M 55.07M 55.14M 55.73M 55.89M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
47.68M 48.76M 49.04M 49.76M 0.00 50.16M 54.66M 55.07M 55.14M 55.73M 55.89M
Normalized Net Operating Profit after Tax (NOPAT)
14 20 19 0.70 17 29 37 47 54 64 69
Normalized NOPAT Margin
9.18% 10.86% 8.88% 0.26% 5.85% 8.78% 9.74% 10.30% 11.31% 12.49% 12.74%
Pre Tax Income Margin
9.55% 13.20% 11.74% -0.75% 6.57% 10.78% 10.76% 12.43% 13.81% 14.99% 16.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.73% 35.78% 50.30% 1,771.76% 71.61% 42.12% 20.62% 44.96% 72.89% 45.10% 49.72%
Augmented Payout Ratio
0.73% 35.78% 50.30% 1,771.76% 71.61% 42.12% 20.62% 44.96% 72.89% 45.10% 49.72%

Quarterly Metrics and Ratios for Sapiens International

No quarterly metrics and ratios for Sapiens International are available.


Frequently Asked Questions About Sapiens International's Financials

When does Sapiens International's financial year end?

According to the most recent income statement we have on file, Sapiens International's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Sapiens International's net income changed over the last 10 years?

Sapiens International's net income appears to be on an upward trend, with a most recent value of $72.32 million in 2024, rising from $14.58 million in 2014. The previous period was $62.87 million in 2023.

What is Sapiens International's operating income?
Sapiens International's total operating income in 2024 was $85.85 million, based on the following breakdown:
  • Total Gross Profit: $238.11 million
  • Total Operating Expenses: $152.26 million
How has Sapiens International revenue changed over the last 10 years?

Over the last 10 years, Sapiens International's total revenue changed from $157.45 million in 2014 to $542.38 million in 2024, a change of 244.5%.

How much debt does Sapiens International have?

Sapiens International's total liabilities were at $212.08 million at the end of 2024, a 11.5% decrease from 2023, and a 287.3% increase since 2014.

How much cash does Sapiens International have?

In the past 10 years, Sapiens International's cash and equivalents has ranged from $47.40 million in 2014 to $190.24 million in 2021, and is currently $163.69 million as of their latest financial filing in 2024.

How has Sapiens International's book value per share changed over the last 10 years?

Over the last 10 years, Sapiens International's book value per share changed from 3.86 in 2014 to 8.58 in 2024, a change of 122.4%.

Remove Ads


This page (NASDAQ:SPNS) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners